Bell Asset Management Ltd lessened its holdings in Amgen Inc. (NASDAQ: AMGN) by 7.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional i
Boston Partners trimmed its position in Amgen Inc. (NASDAQ: AMGN) by 6.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 748,386 shares of the medical research
Shares of Amgen Inc. (NASDAQ: AMGN - Get Free Report) have received an average recommendation of "Hold" from the twenty-one research firms that are presently covering the stock, Marketbeat Ratings rep

The Zacks Analyst Blog NVIDIA, AT&T and Amgen

03:06am, Wednesday, 26'th Nov 2025
NVIDIA, AT&T, and Amgen outperform peers as AI growth, 5G expansion, and strong drug sales drive investor optimism.
Associated Banc Corp cut its position in Amgen Inc. (NASDAQ: AMGN) by 2.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). Th
THOUSAND OAKS, Calif. , Nov. 24, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2025 Global Healthcare Conference at 1:45 p.m.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Bahl and Gaynor Inc. trimmed its stake in Amgen Inc. (NASDAQ: AMGN) by 1.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 288,918 shares of
Stock News AI-led whipsaws hit Wall Street: Nvidia (NVDA) reversed from a post-earnings pop to a sharp drop, fueling a turbulent week in which major indexes fin
Despite low relative strength, medical stocks had solid entries in a choppy market.
Stock News AI and crypto rout rocks markets: Tech-led indexes reversed sharply as investors fretted over lofty AI valuations and tumbling Bitcoin (BTC-USD), whi
17 Capital Partners LLC decreased its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 9.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 5,122 shares o
Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy Underscores IMDELLTRA as a Recognized Standard of Care Treatment for Patients With
Connor Clark and Lunn Investment Management Ltd. trimmed its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 90.0% in the second quarter, according to its most recent filing with the Securities and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE